A novel protein design strategy aimed at developing long-acting medications for severe bleeding disorders_澳门葡京手机版app下载

Elin Martine Doeland, Institute of Clinical Medicine
2025-10-08T12:16:16.000Z
type:structured-article
www.uio.no

A new technology for design of proteins could mean that boys and men with bleeding disorders no longer need to receive treatment as frequently as they do today. “This could have significant implications for patients and their families,” says professor Jan Terje Andersen.